Search | Caixin

GO

Sort by: Newest
Newest Relevance Oldest
Type: All
All News CX Tech Videos Podcast Gallery In-Depth
Time: Any Time
Any time Past 24 Hours Past Week Past Month Past Year Custom Range
Range: All
All Headline Byline Full Text

Reset

Showing search results for di ning an han wei

Cover Story: The Daunting Challenge of Immunizing the World

Zhihang and Wang Zhuoqing contributed to this story. Contact reporter Han Wei (weihan@caixin.com
Scandal-Hit Legend Biotech’s Shares Bounce as Customs Probe Continues

understands to be an investigation relating to suspected violations of import and export regulations under
Cover Story: China Moves to Alter Medical Coverage of 300 Million

will test regulators’ ability to manage the insurance fund, Yang said. Contact reporter Han Wei
Fosun Pharma to Deliver German-Developed Vaccines to Hong Kong, Macao

profit growth, the company said. Contact reporter Han Wei (weihan@caixin.com) and editor Bob
Eli Lilly Ties Up With Shanghai Junshi to Pursue Covid-19 Therapies

this story. Contact reporter Han Wei (weihan@caixin.com) and editor Bob Simison (bobsimison@caixin.com)
China Trials of Gilead’s Experimental Covid-19 Drug Suspended

terminated Friday for similar reasons, said Daniel O’Day, CEO of the American drugmaker, in an open
Two More Covid-19 Vaccine Candidates to Start Human Trials in China

. Contact reporter Han Wei (weihan@caixin.com) and editor Bob Simison (bobsimison@caixin.com)
In Depth: Why There Will Be No Quick Cure for Trade After the Pandemic

reporter Han Wei (weihan@caixin.com) and editor Bob Simison (bobsimison@caixin.com) Jia
In Depth: The Maddening Mystery of Defeating the Covid-19 Epidemic

prepared for future outbreaks, Ding said. Contact reporter Han Wei (weihan@caixin.com) and editor Bob Simison (bobsimison@caixin.com)
In Depth: ICU Doctors Bear the Brunt as Coronavirus Causes Rapid Deterioration

coronavirus epidemic. Di Ning, Wen Simin, Huang Yuxin, Chen Lijin and Wang Yanyu contributed to

OR